# Innerskin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/innerskin

- Industry: Consumer Products
- Headquarters: Paris, France
- Website: www.innerskin.com/
- Total disclosed funding: $20M
- Latest round: Series B (Dec 3, 2025)
- Investors on record: 3

## About

Based in France, Innerskin specializes in advanced medical aesthetics, offering comprehensive skincare treatments designed to enhance individual beauty through innovative scientific methods.Innerskin was founded in 2022 and is headquartered in Paris, France. The company focuses on providing a range of medical aesthetic services. In December 2025, Innerskin raised EUR 12.8 million in venture funding led by new investor IRIS Ventures, with participation from returning investor Label Capital. The founder has not been specified, and there are no mentions of company pivots or subsidiaries. The company operates primarily in urban areas in France, including Paris, Marseille, Lyon, and Toulouse, as well as tourist destinations like Cannes and Saint Tropez. Innerskin specializes in medical aesthetics, offering a comprehensive range of skincare treatments designed to enhance individual beauty through advanced scientific methods. Their core offerings include techniques such as mesotherapy-inspired skincare, Hydrafacial, laser hair removal, Morpheus8 non-surgical facial and body remodeling, hyaluronic acid injections for wrinkle filling, body sculpting through EMSCULPT NEO, microneedling, chemical peels, and photobiomodulation via LED technology. These services are tailored to meet the unique needs of clients seeking to address specific skin concerns, improve skin health, and achieve natural-looking results. The company serves a diverse clientele, including individuals seeking aesthetic enhancements across multiple geographical markets, including key urban areas in France such as Paris, Marseille, Lyon, and Toulouse, as well as prominent tourist destinations like Cannes and Saint Tropez.Innerskin generates revenue through direct-to-consumer transactions, primarily from clients purchasing individual aesthetic treatments and services. The pricing structure reflects the specialized nature of their offerings, with clients paying for specific treatments such as Hydrafacial, laser hair removal, and Morpheus8, among others. Each service is designed to fulfill particular skincare and aesthetic goals, resulting in a tailored experience for the customer. The focus on personalized treatment plans not only enhances customer satisfaction but also fosters repeat business as clients return for ongoing skincare and maintenance. By emphasizing expert consultations and individualized care, Innerskin positions itself as a premium provider in the medical aesthetics sector. The company plans to utilize the December 2025 funding to expand its operations, launch in additional European markets, and speed up the growth of its mesocosmetics product line.

## Funding rounds

- Series B, Dec 3, 2025, $15M — IRIS Ventures, Label Capital
- Seed, Nov 3, 2023, $5.4M — CF Partners Capital Management, Label Capital

## Investors

- CF Partners Capital Management — Seed
- Label Capital (https://capitalatlas.ai/funds/label-capital) — Seed, Series B
- IRIS Ventures (https://capitalatlas.ai/funds/iris-ventures) — Series B